(NASDAQ: IFRX) Inflarx Nv's forecast annual revenue growth rate of 799.8% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Inflarx Nv's revenue in 2024 is $68,575.On average, 3 Wall Street analysts forecast IFRX's revenue for 2024 to be $364,075,271, with the lowest IFRX revenue forecast at $40,040,625, and the highest IFRX revenue forecast at $965,096,828. On average, 3 Wall Street analysts forecast IFRX's revenue for 2025 to be $554,444,889, with the lowest IFRX revenue forecast at $118,944,209, and the highest IFRX revenue forecast at $1,399,066,543.
In 2026, IFRX is forecast to generate $3,600,712,083 in revenue, with the lowest revenue forecast at $203,736,121 and the highest revenue forecast at $6,997,688,044.